Blind Trust in Supplier Certificates and Inadequate Final Testing - An Analysis of FDA Warning Letter
On the Road to 30,000 Members
Let us become the World's Leading GMP/GDP Compliance Community in 2026
Related GMP News
26.10.2026Inadequate Supplier Oversight and missing Tests: Lessons from an FDA Warning Letter
21.10.2026FDA Cites Serious CGMP Deficiencies at Stream2Sea
23.09.2026FDA Inspection as GMP Evidence? Swissmedic Opens Up a New Option
23.09.2026New: Coordination of GMP Inspections for Centrally Authorised Products
16.09.2026How GMP Non-Compliance can stop a Marketing Authorisation Application
10.09.2026FDA Warning Letter: Inadequate Warehouse Controls and Lot Traceability